Q1 2024 |
252 |
$1.32 B |
+$205 M |
-$262 M |
-$57.3 M |
IVV, WFCPRL, BACPRL, APOPRA, VXUS
|
13F-HR |
5/14/2024, 04:03 PM |
Q4 2023 |
253 |
$1.32 B |
+$274 M |
-$263 M |
+$11 M |
IVV, WFCPRL, VXUS, APOPRA, LQD
|
13F-HR |
2/8/2024, 05:14 PM |
Q3 2023 |
236 |
$1.22 B |
+$180 M |
-$347 M |
-$167 M |
IVV, WFCPRL, IEF, VXUS, APOPRA
|
13F-HR |
11/3/2023, 04:45 PM |
Q2 2023 |
248 |
$1.43 B |
+$263 M |
-$289 M |
-$26 M |
IVV, WFCPRL, IEF, VXUS, NEEPRR
|
13F-HR |
8/9/2023, 12:33 PM |
Q1 2023 |
256 |
$1.42 B |
+$235 M |
-$410 M |
-$175 M |
IVV, WFCPRL, NEEPRR, VXUS, IEF
|
13F-HR |
5/15/2023, 12:08 PM |
Q4 2022 |
304 |
$1.58 B |
+$224 M |
-$190 M |
+$33.7 M |
IVV, WFCPRL, NEEPRP, VXUS, IEF
|
13F-HR |
2/13/2023, 05:18 PM |
Q3 2022 |
284 |
$1.49 B |
+$241 M |
-$320 M |
-$79 M |
IVV, NEEPRP, WFCPRL, IEF, VXUS
|
13F-HR |
11/4/2022, 12:48 PM |
Q2 2022 |
295 |
$1.59 B |
+$319 M |
-$308 M |
+$10.4 M |
IVV, AVGOP, NEEPRP, IEF, VXUS
|
13F-HR |
8/11/2022, 04:01 PM |
Q1 2022 |
316 |
$1.83 B |
+$403 M |
-$223 M |
+$180 M |
IVV, AVGOP, DHRPRB, NEEPRP, AGG
|
13F-HR |
5/10/2022, 10:57 AM |
Q4 2021 |
320 |
$1.71 B |
+$395 M |
-$378 M |
+$17.3 M |
IVV, AVGOP, DHRPRB, KKRPRC, AGG
|
13F-HR |
2/11/2022, 08:43 AM |
Q3 2021 |
311 |
$1.66 B |
+$315 M |
-$192 M |
+$123 M |
IVV, AGG, NEEPRP, VXUS, SWT
|
13F-HR |
11/12/2021, 02:09 PM |
Q2 2021 |
325 |
$1.55 B |
+$478 M |
-$345 M |
+$133 M |
IVV, AGG, VXUS, SWT, NEEPRP
|
13F-HR |
8/16/2021, 11:50 AM |
Q1 2021 |
306 |
$1.39 B |
+$234 M |
-$295 M |
-$60.7 M |
IVV, AGG, SWT, NEEPRP, VXUS
|
13F-HR |
5/28/2021, 10:58 AM |
Q4 2020 |
280 |
$1.4 B |
+$294 M |
-$271 M |
+$22.9 M |
IVV, AGG, SWT, CFXA, NEEPRP
|
13F-HR |
2/11/2021, 03:14 PM |
Q3 2020 |
259 |
$1.16 B |
+$129 M |
-$222 M |
-$93.1 M |
IVV, AGG, SWT, DHRPRA, CFXA
|
13F-HR |
11/16/2020, 12:06 PM |
Q2 2020 |
244 |
$1.11 B |
+$236 M |
-$473 M |
-$237 M |
IVV, AGG, DHRPRA, SWT, CCIPRA
|
13F-HR |
8/12/2020, 01:17 PM |
Q1 2020 |
240 |
$1.13 B |
+$115 M |
-$270 M |
-$155 M |
IVV, WFCPRL, AGG, BACPRL, AVGOP
|
13F-HR |
5/13/2020, 02:58 PM |
Q4 2019 |
292 |
$1.5 B |
+$191 M |
-$155 M |
+$35.9 M |
IVV, WFCPRL, BACPRL, AVGOP, AGG
|
13F-HR |
2/12/2020, 04:26 PM |
Q3 2019 |
287 |
$1.37 B |
+$252 M |
-$218 M |
+$34.4 M |
IVV, WFCPRL, BACPRL, BDXA, AGG
|
13F-HR |
11/12/2019, 09:16 AM |
Q2 2019 |
287 |
$1.35 B |
+$243 M |
-$134 M |
+$110 M |
IVV, WFCPRL, BACPRL, BDXA, AGG
|
13F-HR |
8/12/2019, 04:43 PM |
Q1 2019 |
272 |
$1.19 B |
+$218 M |
-$185 M |
+$33 M |
IVV, WFCPRL, BACPRL, BDXA, AGG
|
13F-HR |
5/13/2019, 04:56 PM |
Q4 2018 |
257 |
$1.07 B |
+$126 M |
-$240 M |
-$114 M |
IVV, WFCPRL, BACPRL, BDXA, AGG
|
13F-HR |
2/8/2019, 01:17 PM |
Q3 2018 |
300 |
$1.3 B |
+$262 M |
-$209 M |
+$53.2 M |
IVV, WFCPRL, BACPRL, BDXA, HESPRA
|
13F-HR |
11/13/2018, 02:07 PM |
Q2 2018 |
290 |
$1.22 B |
+$163 M |
-$193 M |
-$30.4 M |
IVV, WFCPRL, BDXA, BACPRL, NEEPRQ
|
13F-HR |
8/7/2018, 03:28 PM |
Q1 2018 |
310 |
$1.23 B |
+$189 M |
-$182 M |
+$7.04 M |
IVV, WFCPRL, BDXA, BACPRL, AGG
|
13F-HR |
5/14/2018, 04:15 PM |
Q4 2017 |
311 |
$1.2 B |
+$148 M |
-$137 M |
+$11.5 M |
IVV, WFCPRL, BACPRL, BDXA, ANTX
|
13F-HR |
2/9/2018, 05:16 PM |
Q3 2017 |
310 |
$1.17 B |
+$125 M |
-$121 M |
+$4.37 M |
IVV, AGNPRA, WFCPRL, BACPRL, ANTX
|
13F-HR |
11/14/2017, 09:35 AM |
Q2 2017 |
1 |
$1.98 M |
$0 |
$0 |
|
FPE
|
NEW HOLDINGS |
11/14/2017, 09:36 AM |
Q2 2017 |
312 |
$1.13 B |
+$155 M |
-$131 M |
+$23.3 M |
IVV, AGNPRA, WFCPRL, BACPRL, ANTX
|
13F-HR |
8/10/2017, 08:08 PM |
Q1 2017 |
306 |
$1.09 B |
+$93.6 M |
-$144 M |
-$50.9 M |
IVV, AGNPRA, WFCPRL, BACPRL, ANTX
|
13F-HR |
5/15/2017, 01:50 PM |
Q4 2016 |
302 |
$1.09 B |
+$137 M |
-$140 M |
-$2.62 M |
IVV, AGNPRA, WFCPRL, BACPRL, AGG
|
13F-HR |
2/10/2017, 02:41 PM |
Q3 2016 |
292 |
$1.09 B |
+$139 M |
-$100 M |
+$39 M |
IVV, AGNPRA, WFCPRL, BACPRL, AGG
|
13F-HR |
11/14/2016, 08:23 AM |
Q2 2016 |
277 |
$999 M |
+$122 M |
-$91.5 M |
+$30.8 M |
IVV, AGNPRA, WFCPRL, BACPRL, FTRPR
|
13F-HR |
8/9/2016, 10:31 AM |
Q1 2016 |
269 |
$952 M |
+$151 M |
-$165 M |
-$13.8 M |
IVV, AGNPRA, WFCPRL, BACPRL, FTRPR
|
13F-HR |
5/9/2016, 12:32 PM |
Q4 2015 |
279 |
$977 M |
+$177 M |
-$144 M |
+$33.1 M |
IVV, AGNPRA, FTRPR, BACPRL, WFCPRL
|
13F-HR |
2/10/2016, 03:23 PM |
Q3 2015 |
274 |
$929 M |
+$168 M |
-$197 M |
-$28.8 M |
AGNPRA, IVV, FTRPR, TYFDL, BACPRL
|
13F-HR |
11/9/2015, 03:56 PM |
Q2 2015 |
292 |
$1.02 B |
+$221 M |
-$262 M |
-$40.6 M |
AGNPRA, IVV, WFCPRL, BACPRL, TYFDL
|
13F-HR |
8/11/2015, 08:21 AM |
Q1 2015 |
295 |
$1.06 B |
+$846 M |
-$770 M |
+$75.7 M |
SPY, ACTPRA, WFCPRL, BACPRL, IVV
|
13F-HR |
5/12/2015, 03:15 PM |
Q4 2014 |
363 |
$985 M |
+$642 M |
-$697 M |
-$54.3 M |
SPY, WFCPRL, BACPRL, HCNPRI, TYFDL
|
13F-HR |
2/11/2015, 03:35 PM |
Q3 2014 |
392 |
$1.03 B |
+$313 M |
-$300 M |
+$12.3 M |
SPY, WFCPRL, BACPRL, HCNPRI, KEYPRG
|
13F-HR |
11/12/2014, 04:09 PM |
Q2 2014 |
388 |
$1.03 B |
+$156 M |
-$140 M |
+$15.8 M |
SPY, HCNPRI, BACPRL, WFCPRL, KEYPRG
|
13F-HR |
8/8/2014, 02:52 PM |
Q1 2014 |
394 |
$980 M |
+$172 M |
-$338 M |
-$167 M |
SPY, HCNPRI, BACPRL, KEYPRG, WFCPRL
|
13F-HR |
5/9/2014, 11:56 AM |
Q4 2013 |
407 |
$1.13 B |
$0 |
$0 |
|
SPY, HCNPRI, KEYPRG, OCRPRB, MTCN
|
13F-HR |
2/7/2014, 08:46 AM |